[Activated serine/threonine kinase AKT enhances the radioresistancy in human cholangiocarcinoma].
Yanagawa
Nobuyuki
N
Third Department of Internal Medicine, Asahikawa Medical College, Asahikawa 078-8510, Japan.
D000368:Aged; D017209:Apoptosis / Q000528:radiation effects; D001650:Bile Duct Neoplasms / Q000201:enzymology*; D001653:Bile Ducts, Intrahepatic; D018281:Cholangiocarcinoma / Q000201:enzymology*; D004789:Enzyme Activation; D005260:Female; D006801:Humans; D008297:Male; D017346:Protein Serine-Threonine Kinases / Q000502:physiology*; D011518:Proto-Oncogene Proteins / Q000235:genetics / Q000502:physiology*; D051057:Proto-Oncogene Proteins c-akt; D011836:Radiation Tolerance / Q000502:physiology*; D014407:Tumor Cells, Cultured
D011518:Proto-Oncogene Proteins; C494918:AKT1 protein, human; D017346:Protein Serine-Threonine Kinases; D051057:Proto-Oncogene Proteins c-akt